The Adrenal Insufficiency drugs in development market research report provides comprehensive information on the therapeutics under development for Adrenal Insufficiency, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Adrenal Insufficiency. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Adrenal Insufficiency and features dormant and discontinued products.
GlobalData tracks five drugs in development for Adrenal Insufficiency by five companies/universities/institutes. The top development phase for Adrenal Insufficiency is pre-registration with two drugs in that stage. The Adrenal Insufficiency pipeline has five drugs in development by companies and 0 by universities/ institutes. Some of the companies in the Adrenal Insufficiency pipeline products market are: Neurocrine Biosciences, Eton Pharmaceuticals and Citrine (Shanghai).
The key targets in the Adrenal Insufficiency pipeline products market include Glucocorticoid Receptor.
The key mechanisms of action in the Adrenal Insufficiency pipeline product include Glucocorticoid Receptor Agonist with five drugs in Pre-Registration. The Adrenal Insufficiency pipeline products include four routes of administration with the top ROA being Oral and one key molecule types in the Adrenal Insufficiency pipeline products market including Small Molecule.
Adrenal Insufficiency overview
Adrenal insufficiency or Addison’s disease is the inability of adrenal glands to make certain hormones like cortisol and aldosterone. It is caused by an autoimmune disease or by suddenly stopping a steroid treatment without weaning. The most common symptoms are fatigue, muscle weakness, loss of appetite, weight loss, and abdominal pain. It can be diagnosed with the help of blood tests, CT scans, and MRI. Glucocorticoids, mineralocorticoids, and androgen replacement are helpful in treating it.
For a complete picture of Adrenal Insufficiency’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
